My Best Pick 2018

Ambareesh Baliga

The independent market expert believes Jyothy Labs’ prima facie bad news should be seen as an investment opportunity

Published 4 years ago on Jan 10, 2018 5 minutes Read
Soumik Kar

I have been a contrarian at heart, looking for interesting ideas among the fallen angels. Many a times such stock or sector-specific pessimism provides excellent entry levels. These stocks tend to try one’s patience but they generally provide a superior risk-return trade-off. Jyothy Laboratories (JLL) grabbed my attention when it fell sharply by 14% early November after Henkel, it’s